Literature DB >> 2372499

Systemic cancer and the FAMMM syndrome.

W Bergman1, P Watson, J de Jong, H T Lynch, R M Fusaro.   

Abstract

The FAMMM syndrome consists of the familial occurrence of cutaneous malignant melanoma and atypical nevi (dysplastic nevi), and is inherited as an autosomal dominant trait. Conflicting results have been reported on the question of whether the syndrome includes increased susceptibility to non-melanoma cancers. We have studied cancer of all anatomic sites and histologies in nine FAMMM families which were ascertained in a pigmented lesions clinic in the Netherlands. We evaluated two hypotheses: that the number of systemic cancers observed in the families was excessive, compared to expected incidence, based on Dutch incidence data, and that there was variation (or heterogeneity) among families in the frequency of systemic cancer. A significant excess of systemic cancer (especially digestive tract cancer) was observed. Significant heterogeneity was also found among the families; three of the nine families had marked excess in numbers of systemic cancers, and the remaining families had normal numbers of cancers among the known FAMMM gene carriers and their first degree relatives. Thus, we provide evidence of increased susceptibility to systemic cancer occurring in conjunction with the FAMMM syndrome in a subset of this resource.

Entities:  

Mesh:

Year:  1990        PMID: 2372499      PMCID: PMC1971693          DOI: 10.1038/bjc.1990.209

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Extracolonic manifestations of familial polyposis coli.

Authors:  D G Jagelman
Journal:  Cancer Genet Cytogenet       Date:  1987-08

Review 2.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

3.  Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.

Authors:  W Bergman; D J Ruiter; E Scheffer; W A van Vloten
Journal:  Cancer       Date:  1988-04-15       Impact factor: 6.860

4.  Dysplastic nevi as precursors to hereditary melanoma.

Authors:  K Kraemer
Journal:  J Dermatol Surg Oncol       Date:  1983-08

5.  The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands.

Authors:  H F Vasen; W Bergman; A van Haeringen; E Scheffer; E A van Slooten
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

6.  Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis.

Authors:  H T Lynch; R M Fusaro; W J Kimberling; J F Lynch; B S Danes
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

7.  Familial breast cancer and its recognition in an oncology clinic.

Authors:  H T Lynch; P R Fain; D Golgar; W A Albano; J A Mailliard; P McKenna
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

8.  Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome.

Authors:  W Bergman; A Palan; L N Went
Journal:  Ann Hum Genet       Date:  1986-07       Impact factor: 1.670

9.  Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma.

Authors:  M H Greene; M A Tucker; W H Clark; K H Kraemer; D E Elder; M C Fraser
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

10.  Tumour spectrum in the FAMMM syndrome.

Authors:  H T Lynch; R M Fusaro; J Pester; J A Oosterhuis; L N Went; P Rumke; H Neering; J F Lynch
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  10 in total
  26 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 2.  Update on familial pancreatic cancer.

Authors:  H T Lynch; R E Brand; C A Deters; R M Fusaro
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 3.  The CDKN2A (p16) gene and human cancer.

Authors:  W D Foulkes; T Y Flanders; P M Pollock; N K Hayward
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 4.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

5.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

Review 7.  Risk factors for pancreatic adenocarcinoma: are we ready for screening and surveillance?

Authors:  Randall Brand; Claudius Mahr
Journal:  Curr Gastroenterol Rep       Date:  2005-05

8.  Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse?

Authors:  Georgi Tchernev; Julian Ananiev; José-Carlos Cardoso; Anastasiya Atanasova Chokoeva; Stanislav Philipov; Plamen Kolev Penev; Torello Lotti; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-08-06

9.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

Review 10.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.